secwatch.observer — SEC 8-K summary
======================================

Issuer:     TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
CIK:        0001027838
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001558370-23-013632
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tactile Medical Q2 revenue $68.3M (+15% YoY); narrows net loss to $0.1M; raises FY23 guidance
--------------------------------------------------------------------------------

- Revenue $68.3M (+15% YoY); lymphedema +16%, airway clearance +4%.
- Net loss $0.1M ($0.00/diluted) vs loss $4.6M ($0.23/diluted) in Q2 2022.
- Adjusted EBITDA $6.1M, up from $1.7M; cash $63.2M; debt $47.5M.
- FY23 revenue guidance raised to $274M-$278M (prev $271M-$275M, +11%-13% YoY).
- Sherri Ferstler appointed SVP of Sales (Jul 31); credit agreement amended to extend maturity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1027838/000155837023013632/0001558370-23-013632-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1027838/000155837023013632/tcmd-20230807x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-013632

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer